Document is current
Any future updates will be listed below
-
Authors
Mutai, Hideki
Miya, Fuyuki
Nara, Kiyomitsu
Yamamoto, Nobuko
Inoue, Satomi
Murakami, Haruka
Namba, Kazunori
Shitara, Hiroshi
Minami, Shujiro
Nakano, Atsuko
Arimoto, Yukiko
Morimoto, Noriko
Kawasaki, Taiji
Wasano, Koichiro
Fujioka, Masato
Uchida, Yasue
Kaga, Kimitaka
Yamazawa, Kazuki
Kikkawa, Yoshiaki
Kosaki, Kenjiro
Tsunoda, Tatsuhiko
Matsunaga, Tatsuo
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (15K10773, 16K07211)
National Hospital Organization of Japan (R3-NHO (kankakuki)-02)
Japan Agency for Medical Research and Development (23gn010063h0002)
- License Information
-
More Information
Article History
Received: 18 October 2024
Accepted: 2 December 2024
First Online: 4 January 2025
Declarations
:
: The authors declare no competing interests.
: This study was performed in line with the principles of the Declaration of Helsinki. This study was approved by the institutional ethics review board at the National Hospital Organization Tokyo Medical Center (R21-053), RIKEN Center for Integrative Medical Sciences (Yokohama H24-15(3)), and the Tokyo Medical and Dental University (O2015-503). All the experimental procedures for generation and use of Zbtb10-deficient mice were approved by National Hospital Organization Tokyo Medical Center (14-animal-05).
: Studies were conducted only after patients or their parents signed informed consent forms to participate.
: The participant has consented to the submission of the case report to the journal.
